Smead Capital Management, Inc. Organon & Co. Transaction History

Smead Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $2.54 Million - $3.12 Million	80,183 Added 6.6%	1,295,225 $43.7 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $30.4 Million - $39.3 Million	997,700 Added 459.05%	1,215,042 $42.4 Million
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $1.18 Million - $1.53 Million	41,228 Added 23.41%	217,342 $6.62 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $121,935 - $151,790	4,259 Added 2.48%	176,114 $5.78 Million
Q2 2021 Jul 30, 2021	BUY	$28.45 - $38.0 $4.89 Million - $6.53 Million	171,855 New	171,855 $5.2 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Smead Capital Management, Inc. with notifications on news.